Silencing of long non-coding RNA linc01106 suppresses non-small cell lung cancer proliferation, migration and invasion by regulating microRNA-765

References

• Bhan A, Soleimani M, Mandal SS. 2017. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 77:3965–3981.
   PubMed Web of Science ®Google Scholar
• Cao ZQ, Wang Z, Leng P. 2019. Aberrant N-cadherin expression in cancer. Biomed Pharmacother = Biomed Pharmacother. 118:109320.
   PubMed Web of Science ®Google Scholar
• Chae YK, Chang S, Ko T, Anker J, Agte S, Iams W, Choi WM, Lee K, Cruz M. 2018. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep. 8:2918.
   PubMed Web of Science ®Google Scholar
• Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. 2014. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 14:535–546.
   PubMed Web of Science ®Google Scholar
• Chuang TD, Rehan A, Khorram O. 2021. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 115:238–247.
   PubMed Web of Science ®Google Scholar
• Ding J, Yang C, Yang S. 2018. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2. J Oral Pathol Med. 47:468–476.
   PubMed Web of Science ®Google Scholar
• Du Q, Liu J, Tian D, Zhang X, Zhu J, Qiu W, Wu J. 2020. Long noncoding RNA LINC00173 promotes NUTF2 expression through sponging miR-765 and facilitates tumorigenesis in glioma. Cancer Manag Res. 12:7211–7217.
   PubMed Web of Science ®Google Scholar
• Du X, Zhang J, Wang J, Lin X, Ding F. 2018. Role of miRNA in lung cancer-potential biomarkers and therapies. Curr Pharm Des. 23:5997–6010.
   PubMed Web of Science ®Google Scholar
• Du Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, et al. 2016. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 7:10982.
   PubMed Web of Science ®Google Scholar
• Elias R, Morales J, Presley C. 2017. Checkpoint inhibitors for non-small cell lung cancer among older adults. Curr Oncol Rep. 19:62.
   PubMed Web of Science ®Google Scholar
• Gao X, Yu L, Zhang J, Xue P. 2020. Silencing of long non-coding RNA LINC01106 suppresses the proliferation, migration and invasion of endometrial cancer cells through regulating the miR-449a/MET axis. Onco Targets Ther. 13:9643–9655.
   PubMed Web of Science ®Google Scholar
• Gester F, Paulus A, Sibille AL, Duysinx B, Louis R. 2016. [Prognostic factors in Non small cell lung cancer]. Rev Med Liege. 71:34–39.
   PubMedGoogle Scholar
• Goebel C, Louden CL, McKenna R Jr., Onugha O, Wachtel A, Long T. 2019. Diagnosis of non-small cell lung cancer for early stage asymptomatic patients. Cancer Genomics Proteomics. 16:229–244.
   PubMed Web of Science ®Google Scholar
• Grant L, Banerji S, Murphy L, Dawe DE, Harlos C, Myal Y, Nugent Z, Blanchard A, Penner CR, Qing G, et al. 2018. Androgen receptor and Ki67 expression and survival outcomes in non-small cell lung cancer. Horm Cancer. 9:288–294.
   PubMed Web of Science ®Google Scholar
• Gu Y, Huang Y, Sun Y, Liang X, Kong L, Liu Z, Wang L. 2020. [Long non-coding RNA LINC01106 regulates colorectal cancer cell proliferation and apoptosis through the STAT3 pathway]. Nan Fang yi ke da xue xue bao = Journal of Southern Medical University. 40:1259–1264.
   PubMedGoogle Scholar
• Guo K, Gong W, Wang Q, Gu G, Zheng T, Li Y, Li W, Fang M, Xie H, Yue C, et al. 2020. LINC01106 drives colorectal cancer growth and stemness through a positive feedback loop to regulate the Gli family factors. Cell Death Dis. 11:869.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. 2018. The biology and management of non-small cell lung cancer. Nature. 553:446–454.
   PubMed Web of Science ®Google Scholar
• Hong S, Li Q, Yang Y, Jing D, Zhu F. 2021. Silencing of long non-coding RNA LINC01106 represses malignant behaviors of gastric cancer cells by targeting miR-34a-5p/MYCN axis. Mol Biotechnol. 64:144–155.
   PubMed Web of Science ®Google Scholar
• Leung YK, Chan QK, Ng CF, Ma FM, Tse HM, To KF, Maranchie J, Ho SM, Lau KM. 2014. Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer. PloS one. 9:e98037.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Wang Y, Yang Q. 2020. H19 promotes the gastric carcinogenesis by sponging miR-29a-3p: evidence from lncRNA-miRNA-mRNA network analysis. Epigenomics. 12:989–1002.
   PubMed Web of Science ®Google Scholar
• Lin C, Garruss AS, Luo Z, Guo F, Shilatifard A. 2013. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. Cell. 152:144–156.
   PubMed Web of Science ®Google Scholar
• Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, Li Y, Liu A, Li X, Chen D, et al. 2020. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol. 11:580593.
   PubMed Web of Science ®Google Scholar
• Liu B, Shyr Y, Cai J, Liu Q. 2018. Interplay between miRNAs and host genes and their role in cancer. Brief Funct Genomics. 18:255–266.
   PubMed Web of Science ®Google Scholar
• Lu T, Wang Y, Chen D, Liu J, Jiao W. 2018. Potential clinical application of lncRNAs in non-small cell lung cancer. Onco Targets Ther. 11:8045–8052.
   PubMed Web of Science ®Google Scholar
• Meng L, Xing Z, Guo Z, Liu Z. 2020. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death Dis. 11:1063.
   PubMed Web of Science ®Google Scholar
• Osielska MA, Jagodzinski PP. 2018. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far? Biomed Pharmacother = Biomed Pharmacother. 101:322–333.
   PubMed Web of Science ®Google Scholar
• Osmani L, Askin F, Gabrielson E, Li QK. 2018. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy. Semin Cancer Biol. 52:103–109.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. 2016. Analyzing MiRNA-LncRNA interactions. Methods Mol Biol. 1402:271–286.
   PubMedGoogle Scholar
• Pennell NA, Arcila ME, Gandara DR, West H. 2019. Biomarker testing for patients with advanced Non-small cell lung cancer: real-world issues and tough choices. Amer Soc Clin Oncol. 39:531–542.
   Google Scholar
• Petrova YI, Schecterson L, Gumbiner BM. 2016. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 27:3233–3244.
   PubMed Web of Science ®Google Scholar
• Rafei H, El-Bahesh E, Finianos A, Nassereddine S, Tabbara I. 2017. Immune-based therapies for non-small cell lung cancer. Anticancer Res. 37:377–387.
   PubMed Web of Science ®Google Scholar
• Salinas-Vera YM, Gallardo-Rincon D, Garcia-Vazquez R, la Cruz ON H-d, Marchat LA, Gonzalez-Barrios JA, Ruiz-Garcia E, Vazquez-Calzada C, Contreras-Sanzon E, Resendiz-Hernandez M, et al. 2019. Hypoxamirs profiling identify miR-765 as a regulator of the Early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells. Front Oncol. 9:381.
   PubMed Web of Science ®Google Scholar
• Shan Y, Wang L, Li G, Shen G, Zhang P, Xu Y. 2019. Methylation of bone SOST impairs SP7, RUNX2, and ERalpha transactivation in patients with postmenopausal osteoporosis. Biochem Cell Biol. 97:369–374.
   PubMedGoogle Scholar
• Skrickova J, Kadlec B, Venclicek O, Merta Z. 2018. Lung cancer. Cas Lek Cesk. 157:226–236.
   PubMedGoogle Scholar
• Sun CC, Zhu W, Li SJ, Hu W, Zhang J, Zhuo Y, Zhang H, Wang J, Zhang Y, Huang SX, et al. 2020. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1alpha pathway. Genome Med. 12:77.
   PubMed Web of Science ®Google Scholar
• Sun F, Liang W, Tang K, Hong M, Qian J. 2019. Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. Peer J. 7:e7451.
   PubMed Web of Science ®Google Scholar
• Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. 2018. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer. 124:667–678.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. 2016. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 17:272–283.
   PubMed Web of Science ®Google Scholar
• van Roy F. 2014. Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer. 14:121–134.
   PubMed Web of Science ®Google Scholar
• Wang W, Hu W, Wang Y, An Y, Song L, Shang P, Yue Z. 2020. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Mol Cancer. 19:18.
   PubMed Web of Science ®Google Scholar
• Xiao W, Wang C, Chen K, Wang T, Xing J, Zhang X, Wang X. 2020. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2. EBioMedicine. 51:102622.
   PubMed Web of Science ®Google Scholar
• Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M, Li X, Li J, Mi C, Zhang J, et al. 2019. Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer. Mol Cancer. 18:171.
   PubMed Web of Science ®Google Scholar
• Yin H, Wang Y, Chen W, Zhong S, Liu Z, Zhao J. 2016. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC. Gene. 594:23–29.
   PubMed Web of Science ®Google Scholar
• Yu DH, Ruan XL, Huang JY, Liu XP, Ma HL, Chen C, Hu WD, Li S. 2020b. Analysis of the interaction network of Hub miRNAs-Hub genes, being involved in idiopathic pulmonary fibers and its emerging role in non-small cell lung cancer. Front Genet. 11:302.
   PubMed Web of Science ®Google Scholar
• Yu Y, Lu X, Yang C, Yin F. 2020a. Long noncoding RNA LINC00173 contributes to the growth, invasiveness and chemo-resistance of colorectal cancer through regulating miR-765/PLP2 axis. Cancer Manag Res. 12:3363–3369.
   PubMed Web of Science ®Google Scholar
• Yuan L, Ma T, Liu W, Chen Y, Yuan Q, Ye M, Yu L, Li J, Niu Y, Nan Y. 2019. LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p. Am J Transl Res. 11:6641–6649.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Luan X, Zha J, Li Z, Wu L, Yan Y, Wang H, Hou D, Huang L, Huang F, et al. 2017. TNF-alpha inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis. Cell Signal. 34:102–109.
   PubMed Web of Science ®Google Scholar
• Zhu X, Niu X, Ge C. 2019. Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis. Cancer Biol Ther. 20:799–811.
   PubMed Web of Science ®Google Scholar